ISPO

Prognostic Indicators

Immature (precursor) myeloma cells may be target cells for treatment of human multiple myelomas

Kawano MD, M.M., Harada MD, H., Huang BS, N., Harada MD, Y., Sakai MD, A., Kuramoto MD, A.

Detection of human albumin mRNA by polymerase chain reaction as a marker of circulating hepatocytes in hepatocellularcarcinoma

Barbu MD, V., Hillaire MD, S., Boucher MD, E., Moukhtar PhD, M., Poupon MD, R..

CD44 isoforms are involved in tumour progression

Gunthert, U. Marston, W., Terpe, A., Stander, R., Jothy, S., Friedrichs, K., Franke, F., Aryee, D., Mackay, C..

Is bone marrow morphology sufficient to gauge complete remission in acute leukemia ? major role of cytogenetic analysis

Raynaud, S.D., Brunet, B., Gratecos, N., Deville, A., Monpoux, F., Bayle, J., Lagrange, M., Ayraud, N..

Detection of the ganglioside fucgm, in sera from patients with small cell lung cancer: variation of serum concentrations at the time of diagnosis and under chemotheapy

Vangsted MD, A., Drivsholm MD, L., Pallesen M.sc., T., Zeuthen PhD., J., Wallin Ph.D, H.

Frequent amplification of 11q13 DNA markers in human head and neck squamous cell carcinomas

Muller, D., Millon, R., Bronner, G., Engelmann, A., Eber, M., Abecassis, J.

The genetic origin of the cancer recognition, immunedefense suppression and serine protease protection (CRISPP) peptide

Cercek PhD, L., Siaw PhD, M., Cercek PhD, B., Cercek D.sc., B.

Identification of endogeneous biotin-like substance in human thyroid lesions

Kashima MD, K., Yokoyama MD, S., Daa MD, T., Nakayama MD, I., Noguchi MD, S.

Debrisoquine and dapsone hydroxylation as risk factors in human bladder carcinogenesis

Branch, R., Persad, R., Fleming, C., Adedoyin, A., Sibley, G., Smith, P., Wilkinson, G.R.